BDBM667103 Methyl 2-{1-[2-({4-[7-(5-chloro-2- fluorophenyl)-1H,2H,3H- pyrido[3,4-b][1,4]oxazin-1- yl]pyridin-2-yl}carbamoyl)ethyl]-4- methylpiperazin-2-yl}acetate::US20240116947, Example 50

SMILES COC(=O)CC1CN(C)CCN1CCC(=O)Nc1cc(ccn1)N1CCOc2cnc(cc12)-c1cc(Cl)ccc1F

InChI Key InChIKey=AWFYHOVZVGUSRU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667103   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM667103(US20240116947, Example 50 | Methyl 2-{1-[2-({4-[7-...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent